Language Select
Logótipo Varian

Notícias recentes

Outubro 12, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported... Read more
Outubro 04, 2018
Varian (NYSE: VAR) today announced it has signed an educational partnership with one of India's leading hospital groups to provide greater access to training in advanced radiotherapy and... Read more
Outubro 03, 2018
Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as president of Proton Solutions, the division formerly... Read more

Publicações recentes do blogue

Set 19, 2018 | Centerline
In a new paper, “The Future of Cancer Care: Moving from Promise to Reality," Varian lays out the company’s vision for how advances in such disparate areas as diagnostics, genomics, precision... Read more
Set 13, 2018 | Blogue Spot ON
Stereotactic body radiation therapy (SBRT) is increasingly used as a result of its ability to spare healthy tissue, as well as for its enhanced tumor control and curative potential. Dr. Simone shares... Read more
Ago 17, 2018 | Centerline
At Sírio-Libanês Hospital in São Paulo, Brazil, patients are now starting radiation treatment on average two days sooner. Reducing the time from simulation to the first day of treatment is just one... Read more

Receber notícias por e-mail
Assinar agora

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com